Free CME from PeerView


Oncology CME

Credits: 1 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care
Prof Eric Van Cutsem, MD, PhD
October 13, 2021
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Anthony R. Mato, MD, MSCE
October 4, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Sagar Lonial, MD, FACP
October 1, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Jared Weiss, MD
September 29, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD
September 28, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Milind Javle, MD
September 28, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Ushering in a New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care
Jackie Weatherly, PA-C
September 27, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
Kenneth R. Cooke, MD
September 24, 2021
Credits: 0.50 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
Sanam Loghavi, MD
September 20, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD
September 14, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD
September 10, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
Nicole Lamanna, MD
September 9, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
September 8, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
Ian W. Flinn, MD, PhD
September 7, 2021
Credits: 1 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
September 1, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP
August 25, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Redrawing the Algorithm in Gastric and GEJ Cancers: Treatment Planning and Sequencing in the Era of Immunotherapy
Manish A. Shah, MD, FASCO
August 23, 2021
Credits: 1.00 NCPD
Medical Learning Institute, Inc.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
August 18, 2021
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
August 10, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers
Jaffer A. Ajani, MD / Ian Chau, MD, FRCP
July 9, 2021
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in Advanced and Early HR+ Breast Cancer: Expert Perspectives on CDK4 and 6 Inhibitors and Other Novel Agents
Sara M. Tolaney, MD, MPH
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
Nina Shah, MD
July 7, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
Deborah K. Armstrong, MD
July 6, 2021
Credits: 1.5 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
Stephen V. Liu, MD
July 5, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
Toni K. Choueiri, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
Jacob Sands, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
Gail J. Roboz, MD
July 5, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView